Literature DB >> 11592551

Oestrogen, glycogen and vaginal candidiasis.

G J Dennerstein1, D H Ellis.   

Abstract

Our aim was to relate vaginal candidiasis to vaginal oestrogenisation. First, the incidence was determined (subjected to chi-square analysis) of vaginal Candida albicans infection in 339 consecutive dermogynaecology clinic patients aged 55 years and over, of whom 142 were using and 197 were not using oestrogen. Second, the ability of Candida species to utilise glycogen as a sole nutrient source was studied by performing assimilation tests using yeast nitrogen broth as a basal medium. infection on initial presentation compared with 4% in the cohort not using oestrogen (p < 0.001). All 34 isolates of C. albicans assimilated glycogen. Twenty-six non-albicans species of Candida tested did not assimilate glycogen. In this study of postmenopausal women, there was a highly significant relationship between the usage of oestrogen and the occurrence of C. albicans infection. The production of glycogen by oestrogen stimulated epithelial maturation provides an attractive substrate for C. albicans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11592551     DOI: 10.1111/j.1479-828x.2001.tb01238.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  20 in total

1.  Cytology in the differential diagnosis of vaginitis.

Authors:  Graeme J Dennerstein
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

Review 2.  Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.

Authors:  Sarah Höfs; Selene Mogavero; Bernhard Hube
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

3.  Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Authors:  W Mendling; K Friese; I Mylonas; E-R Weissenbacher; J Brasch; M Schaller; P Mayser; I Effendy; G Ginter-Hanselmayer; H Hof; O Cornely; M Ruhnke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

4.  Mouse strain-dependent differences in estrogen sensitivity during vaginal candidiasis.

Authors:  Paolo Mosci; Donatella Pietrella; Giovanni Ricci; Neelam Pandey; Claudia Monari; Eva Pericolini; Elena Gabrielli; Stefano Perito; Francesco Bistoni; Anna Vecchiarelli
Journal:  Mycopathologia       Date:  2012-10-07       Impact factor: 2.574

5.  The Interleukin (IL) 17R/IL-22R Signaling Axis Is Dispensable for Vulvovaginal Candidiasis Regardless of Estrogen Status.

Authors:  Brian M Peters; Bianca M Coleman; Hubertine M E Willems; Katherine S Barker; Felix E Y Aggor; Ellyse Cipolla; Akash H Verma; Srinivas Bishu; Anna H Huppler; Vincent M Bruno; Sarah L Gaffen
Journal:  J Infect Dis       Date:  2020-04-07       Impact factor: 5.226

6.  Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry Number 015/072, September 2020).

Authors:  Alex Farr; Isaak Effendy; Brigitte Frey Tirri; Herbert Hof; Peter Mayser; Ljubomir Petricevic; Markus Ruhnke; Martin Schaller; Axel P A Schäfer; Birgit Willinger; Werner Mendling
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-04-14       Impact factor: 2.915

7.  Trans-cellular tunnels induced by the fungal pathogen Candida albicans facilitate invasion through successive epithelial cells without host damage.

Authors:  Joy Lachat; Alice Pascault; Delphine Thibaut; Rémi Le Borgne; Jean-Marc Verbavatz; Allon Weiner
Journal:  Nat Commun       Date:  2022-06-30       Impact factor: 17.694

8.  Genetic susceptibility of mice to Candida albicans vaginitis correlates with host estrogen sensitivity.

Authors:  Karl V Clemons; Jimmy L Spearow; Rachana Parmar; Marife Espiritu; David A Stevens
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Comparative Analysis of the Capacity of the Candida Species To Elicit Vaginal Immunopathology.

Authors:  Hubertine M E Willems; David J Lowes; Katherine S Barker; Glen E Palmer; Brian M Peters
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

10.  The PAV trial: does lactobacillus prevent post-antibiotic vulvovaginal candidiasis? Protocol of a randomised controlled trial [ISRCTN24141277].

Authors:  Marie Pirotta; Jane Gunn; Patty Chondros; Sonia Grover; Susan Hurley; Suzanne Garland
Journal:  BMC Fam Pract       Date:  2004-03-28       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.